2001
DOI: 10.1073/pnas.191235898
|View full text |Cite
|
Sign up to set email alerts
|

Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

Abstract: Prostate cancer (PCa) is an androgen dependent disease that can be treated by androgen ablation therapy, and clinical trials are under way to prevent PCa through the reduction of androgen receptor (AR) activity. However, there are no animal models of AR-mediated prostatic neoplasia, and it remains unclear whether the AR is a positive or negative regulator of cell growth in normal prostate secretory epithelium. To assess the direct effects of the AR in prostate epithelium, a murine AR transgene regulated by the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

9
105
2
2

Year Published

2003
2003
2009
2009

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 154 publications
(118 citation statements)
references
References 70 publications
9
105
2
2
Order By: Relevance
“…On the basis of the pleiotropic activities of IFNs, some downstream mediators, however, may also trigger tumorigenesis, especially when the upregulation is uncoupled from complex IFN-induced responses. In PCa, IFNs not only inhibit the proliferation of PCa cells (Sica et al, 1994) but also upregulate the AR expression (Sica et al, 1994;Basrawala et al, 2006) known to exhibit growth-promoting effects (Stanbrough et al, 2001;Berger et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…On the basis of the pleiotropic activities of IFNs, some downstream mediators, however, may also trigger tumorigenesis, especially when the upregulation is uncoupled from complex IFN-induced responses. In PCa, IFNs not only inhibit the proliferation of PCa cells (Sica et al, 1994) but also upregulate the AR expression (Sica et al, 1994;Basrawala et al, 2006) known to exhibit growth-promoting effects (Stanbrough et al, 2001;Berger et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…The androgen receptor (AR) plays a critical role in the growth, differentiation and function of the prostate, and is also involved in the initiation and progression of PCa. Animal models clearly indicate that AR overexpression in prostatic epithelial cells triggers proliferation and oncogenic transformation (Stanbrough et al, 2001;Berger et al, 2004). In PCa patients, high AR levels are associated with aggressive clinicopathological features and a decreased biochemical recurrence-free survival .…”
Section: Introductionmentioning
confidence: 99%
“…It is well known that the AR is essential for cellular survival in prostate cancer cells, [8][9][10][11][12][13][14][15] but its downstream effectors are not fully listed. In this study, we sought to identify novel downstream mediators responsible for AR-dependent survival.…”
Section: Discussionmentioning
confidence: 99%
“…7 The etiology of hormone-refractory progression may have various molecular causes, but a critical role of the AR has emerged. [8][9][10][11] We and others have recently showed that eliminating AR expression led to a profound apoptotic response in AR-positive prostate cancer cells, suggesting that the AR is essential for cellular survival in prostate cancers. [12][13][14][15] However, the downstream effectors that facilitate AR-dependent survival are not fully elucidated.…”
mentioning
confidence: 99%
“…Both androgen and androgen receptor (AR) are recognized risk factors in the development of prostate cancer [17][18][19][20]. These observations are further corroborated by genetic evidence from transgenic mouse models, suggesting that increased AR signaling in the prostate is linked to an increase in precancerous lesions [21]. Since elevated level of androgen causes enhancement of prostate cancer, reduction of circulating levels of androgens is central to the treatment of prostate cancer [22,23].…”
Section: Introductionmentioning
confidence: 99%